Cancer Research AACR Conference on Molecular Diagnostics - 2008  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 2598-2603, May 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takamatsu, K.
Right arrow Articles by Madry, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takamatsu, K.
Right arrow Articles by Madry, N.

Characterization of Tumor-associated Neural Cell Adhesion Molecule in Human Serum

Kiyoshi Takamatsu1, Bernhard Auerbach, Rita Gerardy-Schahn, Matthias Eckhardt, Gabriele Jaques and Norbert Madry

Research Laboratories of Behringwerke AG, P.O. Box 1140, D-35001 Marburg [K. T., B. A., N. M.]; Department of Medical Microbiology, Medizinische Hochschule Hannover, D-30625 Hannover [R. G. S., M. E.]; and Department of Internal Medicine, University of Marburg, D-35033 Marburg [G. J.], Germany

In human serum, at least two molecular species of the neural cell adhesion molecule (NCAM) with molecular weights of 110,000–130,000 and 150,000–180,000, respectively, can be identified by Western blotting. Both are characterized by the absence of epitopes for monoclonal antibodies KD11 and MG5, which specifically recognize intracellular domains of the human NCAM transmembrane isoforms, NCAM-140 and NCAM-180. In contrast to the Mr 110,000–130,000 molecule also detectable in serum samples from healthy blood donors, the Mr 150,000–180,000 molecule appears to be tumor associated. The only difference between these two species is shown to be the presence of long chains of {alpha}-(2,8)-linked N-acetylneuraminic acids, which are characteristic for the so-called embryonic NCAM form. After treatment with endoneuraminidase N, the Mr 150,000–180,000 molecule can no longer be discriminated from the Mr 110,000–130,000 molecule in Western blotting as well as gel and anion exchange chromatography experiments. The experimental data clearly show that only the embryonic NCAM molecule carrying the poly-{alpha}-(2,8)-linked N-acetylneuraminic acid moiety can be regarded as a specific serum marker for small cell lung cancer.

1 To whom requests for reprints should be addressed.

Received 10/11/93. Accepted 3/17/94.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Takashima, Y. Yoshida, T. Kanematsu, N. Kojima, and S. Tsuji
Genomic Structure and Promoter Activity of the Mouse Polysialic Acid Synthase (mST8Sia IV/PST) Gene
J. Biol. Chem., March 27, 1998; 273(13): 7675 - 7683.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yoshida, N. Kurosawa, T. Kanematsu, N. Kojima, and S. Tsuji
Genomic Structure and Promoter Activity of the Mouse Polysialic Acid Synthase Gene (mST8SiaII). BRAIN-SPECIFIC EXPRESSION FROM A TATA-LESS GC-RICH SEQUENCE
J. Biol. Chem., November 22, 1996; 271(47): 30167 - 30173.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.